Clarapath
PrivateLast Round
Series B
Extension
Jul 24, 2024
Total Funding Raised
$98M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Clarapath operates in Healthcare & Life Sciences and is based in Hawthorne, New York. Its latest recorded funding round was a Series B Extension round in July 2024.
Clarapath is a medical robotics company that provides integrated robotic solutions to automate and improve the processing of human and animal tissue for pathological analysis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clarapath Comparables
Compare Clarapath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Morphle Labs | 85% | |
| Sakura Finetek USA, Inc. | 78% | |
| Danaher | 73% |
For institutional investors. Book with your work email.
Clarapath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 24, 2024 | ||||
| Series B | Nov 18, 2021 | ||||
| Series B | Apr 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Clarapath Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ochsner Ventures | Series B Extension |
| P5 Health Ventures | Series B |
| Epiphron Capital | Series B |
| Northwell Holdings | Series B, Series B Extension |
| East Post Road Ventures | Series B |
| The 4100 Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 235% MoM, from 515 to 1.7K.
- Mar 1, 2026
Launched SectionStar, the next-generation robotic microtomy platform.
For institutional investors. Book with your work email.
Clarapath Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Clarapath's valuation, stock price, and market status.
Is Clarapath a public or private company?
Clarapath is a private company.
What is the current stock price of Clarapath?
Clarapath is a private company, so its shares have no public market price. Caplight tracks Clarapath's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Clarapath worth (valuation)?
Valuation information for Clarapath is not publicly available.
Can I buy Clarapath stock?
Clarapath shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Clarapath's last funding round?
Clarapath's most recent funding round was Series B Extension on July 24, 2024.
Who are the main investors in Clarapath?
Key investors in Clarapath include Northwell Holdings.
Will Clarapath IPO soon?
No public IPO plans have been announced for Clarapath.
How can I track Clarapath secondary market activity?
Caplight tracks bids, offers, and trades in Clarapath's shares on secondary markets.